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ABSTRACT 
 
 
 
Gicheru, Yvonne W. M.S., Purdue University, August 2012.  Biochemical and 
Kinetic Analysis of Arabidopsis Nucleobase Transport. Major Professor: George 
S. Mourad.  
 
 
 
Due to its relevance in plant growth, reproduction and development, inter- 
and intracellular transport of nucleobases remains to be an important area of 
basic research.  In this work, two nucleobase transporters of Arabidopsis thaliana 
from two distinct families were partially characterized with the goal of determining 
their solute transport specificity.  The first transporter studied is nucleobase 
ascorbate transporter 2 (AtNAT2), one of a 12-member putative gene family 
predicted to function as a nucleobase-ascorbate transporters.  The coding 
sequence of AtNAT2 was cloned into a yeast expression vector driven by a yeast 
constitutive promoter.  Yeast expressing AtNAT2 were tested through growth 
studies utilizing toxic purine/pyrimidine analogues as well as through radiolabel 
uptake studies.  We found evidence that AtNAT2 does not transport adenine, 
guanine, cytosine, uracil and xanthine.  The second transporter studied was the 
nucleobase cation sympoter 1 of A. thaliana (AtNCS1).  Here kinetic analysis of 
the recently functionally characterized A. thaliana nucleobase cation symporter 1 
(AtNCS1) was undertaken through radiolabeled uptake assays utilizing yeast 
strains expressing the AtNCS1 gene.  Substrate saturation kinetics was 
approached by gradually increasing the substrate concentration, and the 
apparent Km and Vmax values were determined. 
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CHAPTER 1. INTRODUCTION 
 
 
 
Inter- and Intra- Cellular Transport 
The metabolic activities of cells are maintained by transport of various 
metabolites and ions into and out of the cells; this transport may occur across 
short or relatively long distances.  Because unicellular and multicellular 
organisms differ with regard to regulation of biochemicals, energy requirements 
and homeostatic ion concentration, differences in transport systems between 
these organisms are expected (Nagata et al., 2008).  The need for transport of 
cell sustaining substrates across the plasma membrane makes it imperative that 
cells have well defined transport systems.  These transport systems consist of 
transmembrane proteins which have been shown to account for approximately 
10% of all proteins in a cell.  Most transporters demonstrate a high degree of 
specificity, meaning that different cell types require different transporters, and or 
different relative frequencies of certain types of transporters (de Koning & 
Diallinas, 2000). 
 
Importance of Nucleobases 
Nucleobase transport in cells is vital for DNA and RNA synthesis, 
coenzyme (FAD2+, NAD+, NADP+) function, assembly of signaling molecules 
(cAMP) and as a source of nitrogen for many microorganisms (Gournas et al., 
2008; Diallinas & Gournas, 2008).  Nucleobases also contribute to the 
biochemistry of glycoproteins and carbohydrates, and to the biosynthesis of 
secondary metabolites like cytokinins and caffeine (Zrenner et al., 2006).  
Pharmacologically, nucleobase analogues are used as antimetabolites in the 
treatment of many diseases.  In essence these drugs are similar to the normal
2 
 
nucleobases needed for DNA replication and when incorporated into the growing 
DNA strand, strand extension is inhibited halting cell growth and division.  These 
nucleobase analogues include antiviral drugs (acyclovir, ganciclovir), antibiotics, 
antitumor drugs, immunosuppressants, leukemia chemotherapy (5-Fluorouracil, 
thioguanine) and drugs for treating parasitic diseases (allopurinol, 
pyrimethamine) (de Koning & Diallinas, 2000; Diallinas & Gournas, 2008; 
Pantazopoulou & Diallinas, 2007).  In addition, plants utilize nucleobase 
derivatives like xanthine, hypoxanthine and uric acid as a source of nitrogen for 
growth (Gournas at al., 2008).  
Many nucleobase transporters have been identified and characterized 
biochemically and functionally; in fungi and bacteria some of these transporters 
have been cloned and studied in depth.  The nucleobase families described 
below are categorized based on their degree of homology with previously 
characterized transporters.  This homology may be molecular or physiological. 
Research on nucleobase transporters commonly strives to discover the basis of 
nucleobase specificity, as well as appropriate models for cloning and studying 
nucleobase transporters with relevance to medicine, agriculture and 
pharmacology (de Koning & Diallinas, 2000). 
  
Nucleotide Synthesis and Metabolism 
Two primary pathways are employed for the synthesis of nucleotides: the 
de novo pathway, in which enzymes build purine/pyrimidine nucleotides from 
simple molecules like amino acids, carbon dioxide and tetrahydrofolate; and the 
salvage pathway, in which the by-products of cellular metabolism or catabolism 
of nucleic acids are recycled to make new nucleotides or bases as needed. The 
de novo pathway is believed to be plastidic while the salvage pathway may occur 
in more than one compartment (Moffat & Ashihara, 2002).  Nucleotide de novo 
synthesis pathways have high energy requirements compared to salvage 
pathways and are therefore regulated by the availability of carbon, nitrogen and 
phosphate sources. Cells present in growing tissues have high demands for 
3 
 
nucleotides, and will use salvage pathways for the generation of nucleotides 
necessary for processes like flowering and pollen tube formation for example 
(Schmidt et al. 2006).  In plant embryos, successful germination is dependent on 
the availability of nucleotides during imbibition.  Cellular requirements necessitate 
a balance between the salvage and de novo pathways at germination.  For 
instance, during seed germination, the first stage of growth relies heavily on the 
pyrimidine salvage reactions.  These reactions are later replaced by de novo 
synthesis as development progresses (Stasolla et al., 2003).  As nucleotide 
degradation rarely occurs directly at tissues where nucleotides are in high 
demand, transport systems between cells, and or into and out of storage tissues 
are needed to maintain cellular function (Schmidt et al., 2006).     
    
Nucleoside/Nucleobase Transporters 
Nucleobase transporters can be classified into four distinct families based 
on substrate specificity:  the AzgA family , the Equilibrative Nucleoside 
Transporter family (ENT), the Nucleobase Cation Symporter family 1 (NCS1) or 
Purine Related Transporter family (PRT), and the Nucleobase-Ascorbate 
Transporter family (NAT) or Nucleobase Cation Symporter family 2 (NCS2) 
(Diallinas & Gournas, 2008). 
Members of the AzgA family are specific for adenine and guanine, and 
utilize H+ symport for function.  This family is represented by the AtAzg1 and 
AtAzg2 transporters in A. thaliana.  Another transporter of the family is the A. 
nidulans transporter AzgA, which transports adenine, guanine and hypoxanthine.  
About 10-12 transmembrane regions are predicted for the AzgA family compared 
to the 12-14 transmembrane regions predicted for the NAT family.  There is 
some sequence homology between transmembrane region 1 of NATs and 
transmembrane region 2 of the AzgA family; transmembrane region 2 is highly 
conserved in all proteins of the AzgA family.  However, the AzgA family lacks the 
signature motif ([Q/E/P]-N-X-G-X-X-X-X-T-[R/K/G]) present in all NATs.  The 
similarities between the two families indicate a relatedness but perhaps not
4 
 
enough to be classified under NATs (Diallinas & Gournas, 2008; Goudela, 2005; 
Mansfield et al., 2008; Cecchetto et al., 2004). 
Equilibrative Nucleoside Transporters (ENTs) are conserved 
transmembrane proteins present in protozoans, plants and mammals and are 
especially specific for nucleosides and nucleoside analogues like adenosine, 
uridine and thymidine (Chen et al., 2006; Diallinas & Gournas, 2008; Hyde et al., 
2001; Mohlmann et al., 2001; de Koning & Diallinas, 2000).   These transporters 
are especially important for the synthesis of nucleotides by salvage pathways in 
cells that lack de novo purine biosynthetic pathways such as protozoan parasites 
and some mammalian cells like enterocytes and bone marrow cells (Hyde et al., 
2001).  A. thaliana has eight isoforms of this transporter protein with only two 
having been characterized on the molecular level.  These transport adenosine, 
guanosine and cytidine (Wormit et al., 2007).    
Two transporter families that occur in plants do not seem to share any 
similarities with other nucleobase transporters: Purine Permeases (PUP) and 
Ureide Permease (UPS) are H+ symporters and are specific for adenine, 
cytosine, uracil, uric acid and purine related metabolites like allantoin, caffeine, 
xanthine and cytokinin (Gillissen et al. 2000; Diallinas & Gournas, 2008; 
Desimone et al., 2002).   
The NCS1/PRT family uses a proton symport mechanism to transport 
purines, allantoin, cytosine or thiamine.  Members of the family are found in 
prokaryotes, plants and fungi.  This family is predicted to have 12 
transmembrane regions and shows no sequence similarity to the nucleobase 
ascorbate family.  The NCS1 genes in S. cerevisiae and S. pombe are FUR4 
which encode for a uracil transporter.  The FCY2 transporter of S. cerevisiae is 
specific for adenine, guanine, cytosine and hypoxanthine and in E. coli, CodB 
transports cytosine (de Koning & Diallinas, 2000; Goudela et al., 2005). In plants 
the A. thaliana locus At5g03555 encodes a protein that has significant amino 
acid similarity (20-22% amino acid identity and 52-54% amino acid similarity) to 
the S. cerevisiae NCS1 FUR4 (Figure 1) (Mansfield et al., 2008; Mourad et al., 
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2012).  A detailed relationship between the AtNCS1 amino acid sequence and 
putative orthologs in the plant and bacterial kingdoms is shown in the 
phylogenetic tree below (Figure2) (Mourad et al., 2012).  Greatest degree of 
similarity is seen with the dicots (Vitis and Ricinus) followed by the monocots 
(Zea and Oryza) and to a lesser extent but still significant with the bacteria 
(Bacillus and Escherichia) and yeast (S. cerevisiae).  However, the NCS1 
proteins are all grouped together.  Separate from the NCS1 proteins are the A. 
thaliana nucleobase transporters including AtNAT2 that do not appear to have 
sequence similarity to the NCS1 family.  Recently, the solute specificity for the 
At5g03555 locus was demonstrated for adenine, guanine and uracil through in 
planta and yeast heterologous complementation studies (Mourad et al., 2012).    
The NAT family includes H+ symporters specific for xanthine, uric acid and 
uracil that occur in fungi, plants and bacteria, as well as the mammalian L-
ascorbic acid/Na+ symporters.  Mammalian ascorbate transporters are classified 
under NATs based on their sequence despite the fact that ascorbate is 
structurally unrelated to nucleobases (Gournas et al., 2008; Diallinas & Gournas, 
2008; de Koning &Diallinas, 2000).  The NAT family was determined from 
characterization of the uric acid-xanthine permeases of Aspergillus nidulans 
(UapA and UapC) and the uracil permeases UraA of E.coli and the PyrP of 
Bacillus subtilis (Gournas at al., 2008; Diallinas & Gournas, 2008). The, the UapA 
permease is the most extensively and best studied NAT and is therefore used as 
the model for understanding the family (Leung et al., 2010; Kosti et al., 2010; 
Papageorgiou et al., 2008).  To date, only the Zea mays plant NAT has been 
functionally characterized in the transport of uric acid and xanthine (Argyrou et 
al., 2001).  A study by Maurino et al. (2006) classified the AtNAT proteins into 
clades along with the NAT proteins of other eukaryotes.  According to the 
multiple sequence alignment conducted therein, all AtNAT proteins share 35-
92% amino acid identity with each other and 20% amino acid identity with A. 
nidulans NATs.  The Zea mays NAT (LPE1) was not classified with any of the 
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AtNATs, perhaps indicating a difference in substrate specificity between these 
two members of the NAT family.   
 
Thesis Objective 
The first objective of this study was to determine the solute transport 
specificity of the A. thaliana nucleobase-ascorbate transporter 2 (AtNAT2).  
Therefore, we hypothesized that AtNAT2 is a putative nucleobase-xanthine 
transporter based on two premises: the need for nucleic acids during germination 
based on the expression of the AtNAT2 in A. thaliana seeds and homology with 
the Aspergillus nidulans UapA xanthine transporter (bar.utoronto.ca/efp/cgi-
bin/efpWeb.cgi; Cecchetto et al., 2004).  To accomplish this objective AtNAT2 
was first expressed in Saccharomyces cerevisiae mutant strains deficient for the 
transport of nucleobases.  The yeast expressing AtNAT2 was then grown on 
media containing purine/pyrimidine toxic analogues.  Restored sensitivity to any 
of the toxic analogues was taken to indicate a specificity for that compound by 
the transporter protein encoded by AtNAT2.  As AtNAT2 is homologous to the A. 
nidulans permease UapA which transports uric acid and xanthine, a test for 
radiolabeled xanthine uptake was also done.  The second objective of the study 
was to perform kinetic analysis of the A. thaliana nucleobase cation symporter 1 
(AtNCS1), which was recently shown to transport adenine, guanine and uracil 
(Mourad et al., 2012).  This was done with an assay that utilized radiolabeled 
purines/pyrimidines.  
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Figure 1. Amino acid alignment of AtNCS1and the Saccharomyces cerevisiae 
uracil transporter FUR4 by clustal W (Thompson et al., 1994). Black boxes 
represent amino acid identity while grey boxes indicate amino acid similarity. 
Predicted transmembrane spanning domains are indicated for AtNCS1 (light grey 
bars) and ScFUR4 (black bars) using TMHMM (Krogh et al., 2001; Mourad et al., 
2012).      
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CHAPTER 2. MATERIALS AND METHODS 
 
 
 
Plasmid Generation 
The plasmids pRH163 and pRH369 were generated by cloning the coding 
regions from loci At2g34190 (AtNAT2) and At5g03555 (AtNCS1) respectively into 
the multiple cloning site of the yeast expression vector pRG399 (2µ LEU2 PMA1-
MCS-CYC).  The cDNA (C104691) from the At2g34190 locus was amplified 
using primers C104691A and pUNI51REV and the resulting DNA fragment was 
treated with Xho I and Not I and ligated to the like cleaved sites on pRG399.  
Amplification of the coding region from the At5g03555 locus was done with 
genomic DNA and using primers At5g03555YEA and At5g03555YEB and the 
fragment was treated with Xho I and Sph I (Mourad at al., 2012).  Another 
plasmid pRH183 carrying the coding region of the Zea mays NAT(LPE1) was 
generated by amplifying a DNA fragment from pNS175 with primers LPE1R5A 
and LPE1R5B, restricting with Sal I and Not I and cloning into yeast expression 
vector pRG399 treated with Xho I and Not I.  This was used as a positive control 
for the radiolabel uptake assay. The plasmids were generated by Dr. Neil 
Schultes.  Plasmids were extracted from E. coli grown overnight on LB media 
containing 50 mg/mL ampicillin for 18 hours at 37°C.  The cultures were pelleted 
and DNA extracted using a Spin MiniPrep Kit (Qiagen).  50 µL of extract was 
acquired and quantified using the Nanodrop Spectrophotometer to ensure that 
DNA amount was above 100µg/uL.  The extracted DNA was used to transform 
yeast strains by the lithium acetate method (Gietz & Woods, 2002).  
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Yeast Strains and Transformation 
Three Saccharomyces cerevisiae strains RG191 [Mat α, fcy2∆:: kanMX4,  
his3∆1, leu2∆0, met15∆0, ura3∆0], NC122-sp6 [Mat α leu2 fur4∆] and FY21679-
5C [MAT α  leu2∆1 his3∆200 ura3-52]  (Mourad et al., 2012) were grown on 
Synthetic Complete medium (SC) (0.68% Yeast Nitrogen Base without amino 
acids, 2% glucose, 0.002% histidine, tryptophan methionine, leucine, 0.003% 
uracil , 2.2% agar (solid media) at 28-30°C and pH 5.6.  Plasmids pRH163 and 
pRH369 were used to transform yeast strains RG191 and NC122-sp6.  Due to 
the fcy2 and fur4 gene deletions, RG191 is unable to transport adenine, guanine 
and cytosine and NC122-sp6 cannot transport uracil respectively.  FY1679-5C 
represents the S. cerevisiae wild type and has the ability to transport adenine, 
guanine, cytosine and uracil. The yeast expression vector pRG399 harbors a 
LEU2 selection marker that complements the deleted leucine gene in the mutant 
strains, restoring the ability to synthesize leucine.  Cloned genes in the multicopy 
plasmid were placed under the constitutive promoter PMA1 and CYC terminator 
(Serrano & Villalba, 1995).   Successfully transformed strains were thus able to 
grow on media without leucine.       
 
AtNAT2 Toxic Analogue Growth Experiments 
Purine and pyrimidine uptake by AtNAT2 was assayed using the toxic 
analogues:  8-Azaadenine, 8-Azaguanine, 5-Fluorocytosine and 5-Fluorouracil.  
Overnight cultures of transformed and parental mutant strains were grown for 18 
hours and then serially diluted to 10000, 1000, 100 and 10 cells/µL.  Parent 
strains were grown on SC media while transformed strains were grown on SC 
media without leucine.  Stock solutions of the toxic analogues were added to the 
media at the following concentrations: 0-4 mM 8-AzA and 8-AzG, 0-10 µM 5-FU 
and 0-100 µM 5-FC.  A 30 µL drop of cells at each dilution was plated and growth 
was compared after 48 hours at 30°C between the strains containing AtNAT2 
gene and the control strains.  The same experiment was done for the AtNCS1 
gene by Kevin A. Hunt, a student in the lab of Dr. Mourad.
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Radiolabeled Uptake by Yeast Expressing AtNAT2 and AtNCS1  
Time course for the uptake of 0.5 µM [8-3H]xanthine (Moravek 
Biochemicals, Brea, CA) was performed with yeast cells expressing AtNAT2 and 
Lpe1 (pRH183), a known xanthine and uric acid transporter in maize (Argyrou et 
al., 2001). Time course for the uptake of 0.5 µM [5,6-3H]uracil (12.33 kBq ml_1) 
(Moravek Biochemicals, Brea, CA) was performed with yeast expressing 
AtNCS1(Mourad at al., 2012). Overnight cultures of yeast strains were incubated 
for 12 hours in 5 mL of SC media without leucine.  Cultures were then transferred 
into a total volume of 30 mL of media and incubated for another 18 hours.  Cells 
were harvested by centrifugation, washed and re-suspended with 100 mM Citrate 
buffer, pH 3.5 with 1% glucose at an OD600 = 4 and stored on ice.  Yeast 
suspensions were pre-incubated at 30 °C for 2 minutes and equal volumes (50 
µL) of yeast suspension and buffer containing radiolabeled compound were 
mixed.  Final radiolabeled compound concentration in the samples was 0.5 µM.  
The mixture was incubated at 30 °C for 2 minutes with 50 µL aliquots taken at 
time 0 up to 10 minutes at two minute intervals.  Samples were then transferred 
into 4 mL of ice cold water to stop the uptake reaction.  Samples were filtered 
through a 0.45 µm Metricel membrane filter (Gelman Scientific, Ann Arbor MI) 
and then washed with 8 mL of water.  Filters were placed in scintillation tubes 
and 3 mL scintillation fluid (EcoLume) was added.  A liquid scintillation counter 
was used to measure radioactivity (Beckman Coulter, Fullerton, CA).  Substrate 
saturation kinetics was done for varying concentrations of [5,6-3H]uracil (0-10 
µM) and [2,8-3H]adenine (3.7 kBq ml_1) (0-20µM) at 2.5 minutes using yeast cells 
expressing AtNCS1 in the same manner as described above.  Statistical analysis 
of at least three independent experiments was done using a student’s unpaired t-
test and significance was measured at P = 0.05.
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Table 1. Yeast strains and plasmids used in this study. 
 
Yeast strain 
or plasmid 
Genotype Substrate Screen/assay 
RG191 MAT α, fcy2∆:: 
kanMX4,  his3∆1, 
leu2∆0, met15∆0, 
ura3∆0 
Adenine, guanine,
cytosine 
8-Aza, 8-Azg, 5-FC 
NC122-sp6 MAT α leu2 fur4∆ Uracil 5-FU 
FY1679-5C MAT α  leu2∆1 
his3∆200 ura3-52 
Adenine, guanine, 
cytosine, uracil 
8-Aza, 8-Azg, 5-FC 
pRG399 2µ LEU2 PMA1-
MCS-CYC (empty 
expression vector) 
Adenine, guanine, 
cytosine, uracil 
8-Aza, 8-Azg, 5-FC 
pRH163 At2g34190 
(AtNAT2) in 
expression vector  
Adenine, guanine, 
cytosine, uracil 
8-Aza, 8-Azg, 5-FC 
[3H]xanthine 
pRH369 At5g03555 
(AtNCS1) in 
expression vector 
Adenine, guanine, 
cytosine, uracil 
8-Aza, 8-Azg, 5-FC 
[3H]-adenine, 
guanine, uracil 
pRH183 Lpe1 gene in 
expression vector 
 [3H]xanthine 
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CHAPTER 3. RESULTS 
 
 
 
Toxic Analogue Experiments 
Heterologous complementation studies were performed in S. cerevisiae in 
an attempt to establish the solute transport specificity of AtNAT2 at locus 
At2g34190.  The purine/pyrimidine toxic analogues 8-Aza, 8-Azg, 5-FC and 5-FU 
were added to SC media for control strains and SC media without leucine for 
experimental strains.  Strain RG191/pRH163 (AtNAT2) was able to grow well on 
all the toxic analogues indicating that this gene does not mediate transport of 
these specific purines/pyrimidines (Figures 3-6).  The positive control strain 
FY1679-5C showed increasing sensitivity with increase in concentrations of 8-
Aza, 8-Azg and 5-FC while the negative control strains RG191 and 
RG191/pRG399 (empty vector) showed comparable growth to yeast expressing 
AtNAT2.  Strain NC122-sp6/pRH369 (AtNCS1) showed heightened sensitivity to 
5-FU indicating that this gene mediates uracil transport (Figure 6).  In addition, 
yeast expressing AtNCS1 showed sensitivity to 8-Azaadenine and 8-Azaguanine 
indicating that the transporter mediates these substrates as well (See Appendix).  
Work on the AtNCS1 gene was completed by Kevin A. Hunt, a student in the lab 
of Dr. Mourad.                 
 
Radiolabel Uptake by Yeast Expressing AtNAT2 
A time course experiment for the uptake of 0.5 µM [8-3H]xanthine was 
done in three yeast strains: RG191 (negative control), Lpe1 (positive control 
known to transport xanthine) and RG191/pRH163 (AtNAT2).  There was no 
significant difference in uptake between AtNAT2 and the two controls at P=0.05
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(Figure 7).  This indicates that AtNAT2 does not mediate xanthine transport in A. 
thaliana. 
 
Radiolabel Uptake by Yeast Expressing AtNCS1 
Radiolabeled adenine, guanine and uracil were used to perform uptake 
experiments on yeast expressing AtNCS1.  Results show significant uptake in 
yeast expressing the transporter gene, as compared to the mutant control strains 
deficient in the fcy2 (RG191) and fur4 (NC122-sp6) transporters matching the 
toxic analogue growth experiments (see appendix).  This work was completed by 
Julie Crosby, a student in the lab of Dr. Mourad.  
 
Transport Kinetics of Yeast Expressing AtNCS1 
Yeast cells expressing AtNCS1 were used in a time course reaction for 
the uptake of [5,6-3H]uracil.  The results showed a linear relationship up to 10 
minutes (Figure 8).  The graph suggests that this linear relationship could 
continue for a longer time interval before plateauing.  Substrate saturation for 
[5,6-3H]uracil was approached at 10 µM concentrations (Figure 9) and a 
Lineweaver-Burk plot established an apparent Km of 7.0 µM and a Vmax of 0.30 
nmol / 10
9
cells / min (Figure 10).  For [2,8-3H]adenine substrate saturation was 
approached at 30 µM concentrations (Figure 11) and the Lineweaver-Burk plot 
showed an apparent Km of 7.9 µM and a Vmax of 3.3 nmol / 10
9
 cells / min (Figure 
12).
       
    
 
 
 
15 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Growth of Saccharomyces cerevisiae expressing AtNAT2 on 8-
Azaadenine.  fcy2 mutant deficient for adenine, guanine and cytosine transport 
(RG191); fur4 mutant deficient for uracil transport (NC122-sp6); wild type for 
FCY2 and FUR4 (FY1679-5C); empty expression vector (pRG399); expression 
vector with AtNAT2 coding region placed under constitutive transcriptional control 
(pRH163). Strains grown on increasing concentrations (0-4mM) 8-Azaadenine. 
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Figure 4. Growth of Saccharomyces cerevisiae expressing AtNAT2 on 8-
Azaguanine.  fcy2 mutant deficient for adenine, guanine and cytosine transport 
(RG191); fur4 mutant deficient for uracil transport (NC122-sp6); wild type for 
FCY2 and FUR4 (FY1679-5C); empty expression vector (pRG399); expression 
vector with AtNAT2 coding region placed under constitutive transcriptional control 
(pRH163). Strains grown on increasing concentrations (0-4mM) 8-Azaguanine. 
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Figure 5. Growth of Saccharomyces cerevisiae expressing AtNAT2 on 5-
Fluorocytosine.  fcy2 mutant deficient for adenine, guanine and cytosine 
transport (RG191); fur4 mutant deficient for uracil transport (NC122-sp6); wild 
type for FCY2 and FUR4 (FY1679-5C); empty expression vector (pRG399); 
expression vector with AtNAT2 coding region placed under constitutive 
transcriptional control (pRH163). Strains grown on increasing concentrations (0-
400mM) 5-Fluorocytosine. 
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Figure 6. Growth of Saccharomyces cerevisiae expressing AtNAT2 and AtNCS1 
on 5-Fluorouracil.  fcy2 mutant deficient for adenine, guanine and cytosine 
transport (RG191); fur4 mutant deficient for uracil transport (NC122-sp6); wild 
type for FCY2 and FUR4 (FY1679-5C); empty expression vector (pRG399); 
expression vector with AtNAT2 coding region placed under constitutive 
transcriptional control (pRH163); expression vector with AtNCS1 coding region 
placed under constitutive transcriptional control (pRH369).  Strains grown on 
increasing concentrations (0-10mM) 5-Fluorouracil. 
 
 
 
 
 
0 uM 
5 uM 
10 uM 
NC122-sp6 NC122sp6/ 
pRG399 
NC122-sp6/ 
pRH369 
NC122-sp6/ 
pRH163 
5-Fluorouracil 
19 
 
 
 
 
 
 
 
 
Figure 7. Uptake of [8-3H]xanthine in Saccharomyces cerevisiae expressing 
AtNAT2.  RG191 (fcy2 mutant deficient in adenine, guanine and cytosine 
transport); RG191 expressing AtNAT2 (pRH163 cloned into RG191); Lpe1 (Zea 
mays xanthine-uric acid transporter cloned into RG191). There was no significant 
difference in uptake between AtNAT2 and the controls.     
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Figure 8. Time dependence of AtNCS1 mediated [5,6-3H]uracil uptake in 
Saccharomyces cerevisiae.  Uptake rate remained constant during the first 10 
minutes.   
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Figure 9. Substrate saturation with varying concentrations of [5,6-3H]uracil.  
Yeast expressing AtNCS1 approach saturation with increasing concentrations.  
 
 
 
 
 
 
22 
 
 
 
 
Figure 10. Lineweaver-Burk plot for [5,6-3H]uracil in yeast expressing AtNCS1 
reveals a Km apparent of 7.0 µM and a Vmax of 0.304 nmol / 10
9
cells / min.   
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Figure 11. Substrate saturation with varying concentrations of [2,8-3H]adenine . 
Yeast expressing AtNCS1 approach saturation with increasing concentrations.   
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Figure 12.  Lineweaver-Burk plot for [2,8-3H]adenine in yeast expressing AtNCS1 
reveals a Km apparent of 7.9 µM and a Vmax of 3.3 nmol / 10
9
cells / min.   
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CHAPTER 4. DISCUSSION 
 
 
 
Biochemical Analysis of AtNAT2 
Saccharomyces cerevisiae mutant strains RG191 (fcy2∆) and NC122-sp6 
(fur4∆) were transformed with plasmid pRH163 in order to elucidate the solute 
transport specificity of AtNAT2.  The transformations were successful as verified 
by growth on SC media without leucine.  A gel electrophoresis image (Figure 13) 
of a restriction digest of plasmid pRH163 with Xho I and Not I correctly showed 
the expression vector band at 7.75kb and the AtNAT2 band at 1.66 kb.  Yeast 
heterologous complementation studies are crucial for a definitive functional 
characterization of transporter genes in A. thaliana.  This is due to the presence 
of at least six multigene families in A. thaliana, which creates the possibility of 
transport redundancy, necessitating the use of another host.  Additionally, 
manipulating plant cells is difficult which substantially decreases their usefulness 
in primary transport studies.  Finally, S. cerevisiae represents a well 
characterized, simple eukaryote, making it an ideal model organism for the 
expression and study of transporters that occur in higher organisms (Serrano & 
Villalba, 1995).  Even more importantly, S. cerevisiae does not possess any NAT 
homologues (Diallinas & Gournas, 2008). 
AtNAT2 is strongly expressed during germination of A. thaliana seeds. 
Using histochemical analysis of GUS (beta-glucuronidase reporter gene) activity 
the expression pattern of AtNAT2 was visualized in the major and minor veins of 
A. thaliana young leaves and cotyledons at 4 days after imbibition.  This pattern 
was also evident in mature leaves, pediceles and root tips (Maurino et al., 2006). 
Seeds imbibe water during germination, allowing them to swell, and supporting 
an increase in metabolic activity necessary to produce energy for germination.
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In addition, during the early phases of imbibition seeds need an ample 
supply of purine and pyrimidine nucleotides for nucleic acid synthesis (Stasolla et 
al., 2003; Schmidt et al., 2004).  The expression pattern and localization of 
AtNAT2 in the vasculature of young leaves and cotyledons makes it a likely 
candidate for being a transporter of these nucleobases.  Results of this study 
(Figures 3-6) however, did not support this supposition.  Yeast expressing 
AtNAT2 did not show sensitivity to any of the toxic analogues used in the 
heterologous complementation assays indicating that the transporter encoded by 
this gene does not mediate transport of purines/pyrimidines.  
The UapA and UapC uric acid/xanthine transporters of A. nidulans are two 
of the most well characterized NAT proteins and have thus been used to define 
the NAT family.  AtNAT2 has about 20% homology with the A. nidulans 
transporters belonging to the NAT family, prompting our group to test it for 
xanthine transport (Gournas et al., 2008).  Results of the study (Figure 7) showed 
that yeast expressing AtNAT2 does not mediate xanthine transport.  S. 
cerevisiae does not have transporters for the oxidized purines xanthine and uric 
acid, allowing for a clear analysis of the mediation of these solutes by AtNAT2 
(Argyrou et al., 2001). 
 
Lack of Uptake by AtNAT2 
A. thaliana possesses six distinct multigene families which show specific 
yet overwhelming overlap in terms of solutes transported.  AtNAT2 is one of 12 
members of the NAT family and is classified in clade I together with AtNAT1 and 
3 because expression of these genes is seen in the same tissues (Maurino et al., 
2006).  There is strong expression of the 12 NAT genes in embryos, young 
leaves, roots and developing seeds, and high degree of functional redundancy 
occurs within this family.  In addition, other gene families like the purine 
permease (PUP) family have members that transport adenine, cytosine and 
secondary compounds including caffeine and cytokinins (Gillissen et al., 2000; 
Burkle et al., 2003).  The ureide permease (UPS) family has members that 
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mediate allantoin, uracil, thymine and xanthine transport (Desimone et al., 2002; 
Schmidt et al., 2004 & 2006). Finally, the AtAzgA gene transports adenine and 
guanine (Mansfield et al., 2009).  The functional redundancy within and across 
gene families in A. thaliana could explain why there was no solute uptake 
demonstrated when AtNAT2 was isolated for testing. 
Using yeast to express a plant gene does not necessarily mirror transport 
as it occurs naturally in plants.  Heterologous proteins are often poorly localized 
in yeast and many are retained within the endoplasmic reticulum.  Because of 
this challenge, some specific S. cerevisiae strains have been developed to 
optimize expression of eukaryotic transporters at the plasma membrane. Npi1 is 
a mutation in the Rsp5 gene, which encodes a ubiquitin ligase that targets 
proteins for degradation (Serrano& Villalba, 1995; Leung et al., 2010).  In 
addition, the glycosylation process in yeast differs from that in higher organisms 
meaning that the resulting protein may possess long outer carbohydrate chains, 
which may render it inactive or differently active from the natural plant protein 
(Serrano& Villalba, 1995).  These are possibilities that could have taken place 
when AtNAT2 was being expressed.  There were no assays conducted to check 
what portion of the expressed protein found its way to the plasma membrane of 
the yeast.  However, AtNAT2 was placed under constitutive control, meaning that 
there was continuous transcription of the gene, thus continuous production of 
membrane protein, increasing the likelihood that some proteins did reach the 
plasma membrane.   
It is possible that AtNAT2 only functions under certain physiological 
conditions.  It is not known whether AtNAT2 is constitutively expressed in planta, 
for example; changes that occur during expression in yeast may disrupt the 
environment required for in vivo function of this gene.  In addition, the toxic 
analogues themselves may have contributed to the inconclusive results.  
Changes to the purines/pyrimidines may have caused steric hindrance thereby 
blocking their own uptake.  For example, the additional nitrogen at position ‘8’ in 
8-azaadenine may have caused steric hindrance blocking the site for its uptake; 
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using a variety of toxic analogues with the same general structure may establish 
affinity or recognition by the transporter that was not observed in this study 
(Leung et al., 2010).     
 
Kinetic Analysis of AtNCS1 
Recently, Mourad et al. (2012) successfully showed that AtNCS1 
mediates adenine, guanine and uracil transport.  The study included in planta 
radiolabel nucleobase uptake and yeast heterologous complementation studies 
where yeast expressing AtNCS1 was grown on media containing toxic 
purine/pyrimidine analogues.   Radionucleobase uptake studies were also done 
(This work was completed by Julie Crosby and Kevin Ann Hunt, students in the 
lab of Dr. Mourad).  Yeast expressing AtNCS1 showed sensitivity to toxic 
purine/pyrimidine analogues compared to the control strains, indicating transport 
of these nucleobases.  The finding stands in stark contrast to the canonical NCS 
transport pattern seen in FUR4 and FCY2 of S. cerevisiae.  These two genes 
mediate the transport of adenine, guanine cytosine or uracil while AtNCS1 
transports adenine, guanine and uracil.  A difference is also evident when 
comparison is made between the AtNCS1 gene and the A. nidulans furD gene, 
which transports uracil but has no affinity for adenine, guanine or cytosine (Amilis 
et al., 2007).  Interesting to note are the similar transport specificities seen in the 
distantly related AtAZG1 and AtAZG2 families which mediate adenine and 
guanine (Mansfield et al., 2009).   Experiments to determine the kinetics of this 
gene were performed and a constant uptake rate of [5,6-3H]uracil was evident 
during the first 10 minutes.  Substrate saturation was approached in both [5,6-
3H]uracil and [2,8-3H]adenine with increasing concentrations of both compounds.  
Line weaver-Burk plots of uracil and adenine established an apparent Km of 7.0 
µM and 7.9 µM and Vmax of 0.3 nmol / 10
9
 cells / min and 3.3 nmol / 10
9
 cells / 
min respectively.  It is interesting to note the ten-fold increase evident in the 
transport capacity of adenine compared to uracil.  This may be because profiles 
of various plant materials have shown that the adenine nucleotide pool is always
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the largest and also because of its more general role as a cofactor in metabolism 
and synthesis of nucleic acids (Stasolla et al., 2003; Zrenner et al., 2006).  Up to 
date locus At5g03555 codes for the only known nucleobase cation sympoter 1 in 
A. thaliana.     
  
Conclusion 
AtNAT2 showed no uptake of purines or pyrimidines (Figures 3-6) though 
many variables may have affected these results.  AtNAT2 was placed under 
control of a constitutive promoter allowing for continuous protein production but 
perhaps not enough to show a significant difference in the uptake of substrates.  
A different approach would be to use an inducible promoter to increase the levels 
of production and attempt to identify optimal expression levels of this transport 
protein (Leung et al., 2010).  Testing for the sub-cellular expression and 
localization of AtNAT2 would increase confidence in the function of the 
heterologous system used in this study.  Various methods such as northern 
blotting or a green fluorescent protein (GFP) tag would verify expression of the 
plant membrane proteins in yeast.      
Functional redundancy among multigene families present in A. thaliana 
pose a challenge in attempting to establish the solute specificities of genes 
whose functions are still unknown.  Triple homozygous knockout AtNAT mutants 
in A. thaliana plants do not show phenotypic differences compared to the wild 
type but perhaps an in depth analysis of these mutants may offer deeper insight 
into the functions of these genes (Maurino et al., 2006).  As research continues 
within the AtNAT family it is worth noting that sequence homology may not 
always be extended to functional conservation.  An example is the mammalian 
ascorbate transporter classified under the NAT family based on sequence 
homology with plants and fungi while their solute specificities are structurally 
unrelated (de Koning & Diallinas, 2000).      
AtNCS1 has been shown to effectively transport adenine, guanine and 
uracil in A. thaliana (see Appendix), though this is a departure from the canonical
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NCS1 pattern of transport seen in S. cerevisiae FUR4 and FCY2.  The finding 
contributes to the understanding of the multigene families of Arabidopsis (Mourad 
et al., 2012).   
 
 
 
 
Table 2. Resistance of yeast expressing AtNAT2 to a panel of toxic purine and 
pyrimidine analogues incorporated in the growth medium (+= sensitive; - = 
resistance).   
 
Toxic analogue AtNAT2          
8-Azaadenine           -            
8-Azaguanine           - 
5-Fluorocytosine           - 
5-Fluorouracil           - 
 
 
Table 3. Resistance of yeast expressing AtNCS1 to a panel of toxic purine and 
pyrimidine analogues incorporated in the growth medium (+= sensitive; - = 
resistance). Toxic analogues were tested by Kevin Ann Hunt, a student in Dr. 
Mourad’s lab.    
Toxic analogue AtNCS1          
8-Azaadenine           +           
8-Azaguanine           + 
5-Fluorocytosine           - 
5-Fluorouracil           + 
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Figure 13. Gel electrophoresis image of a restriction digest for plasmid pRH163 
(AtNAT2) with Xho I and Not I. AtNAT2 band is seen at approximately 1.66 kb 
and the remaining 7.75 kb is pRG399 (empty expression vector). 
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A.2. RG191 and RG191+pRH369 were incubated (A) [3H]-adenine, (B) -guanine, 
or (C) -uracil in citrate buffer (pH 3.5) and aliquots were taken at 0 and 2.5 min. 
Values shown are the mean of at least three independent experiments. Error 
bars indicate the standard error of the mean. Statistical analysis used an 
independent paired t-test. Significance was measured at *P = 0.05 (Mourad et 
al., 2012). This work was performed by Julie Crosby a student in the lab of Dr. 
George Mourad. 
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